Tavneos 10 mg, Hartkapseln

7680667720027 CH-66772 Kapseln
Tavneos 10 mg, Hartkapseln
Tavneos 10 mg, Hartkapseln
Tavneos 10 mg, Hartkapseln
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/09/2025
Summary of Product Characteristics
Français
19/09/2025
Summary of Product Characteristics
Italien
19/09/2025
Patient information leaflet
Allemand
19/03/2025
Patient information leaflet
Français
19/03/2025
Patient information leaflet
Italien
19/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
245.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 5891.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Vifor Fresenius Medical Care

9014 St. Gallen

Authorization information

Swissmedic authorization number
66772
Drug name
Tavneos, Hartkapseln
Galenic form
KAHA
ATC Code
L04AJ05
Authorization status
Z
Dispensing category
B
First authorization
19/09/2022
Authorization expiration date
18/09/2027
IT Number
07.15.0.
Domain
Human medicine
Field of application
Behandlung erwachsener Patienten mit schwerer aktiver Vaskulitis (Granulomatose mit Polyangiitis (GPA) oder mikroskopischer Polyangiitis (MPA))

Package details

Description (FR)
TAVNEOS caps 10 mg fl 180 pce
Description (DE)
TAVNEOS Kaps 10 mg Fl 180 Stk
Market launch
19/09/2022
Narcotic (BTM)
No

Other package sizes (1)

TAVNEOS caps 10 mg fl 30 pce
30 KAP
GTIN: 7680667720010
View